ArticleMolecular psychiatry2016
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
Article in Molecular psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Microglial purinergic signaling in Alzheimer's disease.Purinergic signalling · 2025Review
- Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review.Pharmaceutics · 2024Review
- Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists.Molecules (Basel, Switzerland) · 2024Article
- Targeting the adenosine AChinese journal of traumatology = Zhonghua chuang shang za zhi · 2024Review
- Article
- Adenosine AProceedings of the National Academy of Sciences of the United States of America · 2022Article
- Single Stabilizing Point Mutation Enables High-Resolution Co-Crystal Structures of the Adenosine AAngewandte Chemie (International ed. in English) · 2022Article
- International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.Pharmacological reviews · 2022Review
- Caffeine Functions by Inhibiting Dorsal and Ventral Hippocampal Adenosine 2A Receptors to Modulate Memory and Anxiety, Respectively.Frontiers in pharmacology · 2022Article
- Astrocytes and Adenosine AFrontiers in neuroscience · 2021Review
- Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy.Acta neuropathologica communications · 2020Article
- Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models.Acta neuropathologica communications · 2019Article
- Adenosine ABritish journal of pharmacology · 2018Article
- Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology.Brain pathology (Zurich, Switzerland) · 2018Article
- Istradefylline reduces memory deficits in aging mice with amyloid pathology.Neurobiology of disease · 2018Article
- Review
- The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.Scientific reports · 2016Article
- The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.Scientific reports · 2015Article
- Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory.Nature neuroscience · 2015Article
Corrections and comments
- Erratum forA2A adenosine receptor deletion is protective in a mouse model of Tauopathy.2016 · Mariciniak, E [Corrected to Marciniak, E]
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
26216297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.